Up-Regulation of Imp3 Confers In Vivo Tumorigenicity on Murine Osteosarcoma Cells

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Ueki, Arisa ^a   Shimizu, Takatsune ^a,b,d   Masuda, Kenta ^a   Yamaguchi, Sayaka I ^a   Ishikawa, Tomoki ^a,c   Sugihara, Eiji ^a,d   Onishi, Nobuyuki ^a   Kuninaka, Shinji ^a   Miyoshi, Keita ^a   Muto, Akihiro ^b   Toyama, Yoshiaki ^a   Banno, Kouji ^a   Aoki, Daisuke ^a   Saya, Hideyuki ^a,d  

^a KEIO UNIVERSITY   (Japan)

^b HOSHI UNIVERSITY   (Japan)

^c DAIICHI SANKYO CO   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; INSULIN LIKE GROWTH FACTOR 2 BINDING PROTEIN 3; MESSENGER RNA; SOMATOMEDIN B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANOIKIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; IMP3 GENE; IN VITRO STUDY; IN VIVO STUDY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; OSTEOSARCOMA; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MOLECULAR TARGETED THERAPY; OSTEOSARCOMA; PHENOTYPE; RNA-BINDING PROTEINS; UP-REGULATION;

MURINAE; MUS;

EID: 84870590981     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050621     Document Type: Article

References (33)

1. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
2. Simpson CD, Anyiwe K, Schimmer AD, (2008) Anoikis resistance and tumor metastasis. Cancer Lett 272: 177-185.
3. Shimizu T, Ishikawa T, Sugihara E, Kuninaka S, Miyamoto T, et al. (2010) c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis. Oncogene 29: 5687-5699.
4. Thullberg M, Stromblad S, (2008) Anchorage-independent cytokinesis as part of oncogenic transformation? Cell Cycle 7: 984-988.
5. Fujino RS, Tanaka K, Morimatsu M, Tamura K, Kogo H, et al. (2006) Spermatogonial cell-mediated activation of an IkappaBzeta-independent nuclear factor-kappaB pathway in Sertoli cells induces transcription of the lipocalin-2 gene. Mol Endocrinol 20: 904-915.
6. Kitamura T, Koshino Y, Shibata F, Oki T, Nakajima H, et al. (2003) Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol 31: 1007-1014.
7. Nielsen FC, Nielsen J, Christiansen J (2001) A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking. Scand J Clin Lab Invest Suppl 234: 93-99.
8. Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, et al. (1999) A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 19: 1262-1270.
9. Mori H, Sakakibara S, Imai T, Nakamura Y, Iijima T, et al. (2001) Expression of mouse igf2 mRNA-binding protein 3 and its implications for the developing central nervous system. J Neurosci Res 64: 132-143.
10. Mueller-Pillasch F, Lacher U, Wallrapp C, Micha A, Zimmerhackl F, et al. (1997) Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene 14: 2729-2733.
11. Jiang Z, Chu PG, Woda BA, Rock KL, Liu Q, et al. (2006) Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study. Lancet Oncol 7: 556-564.
12. Chen ST, Jeng YM, Chang CC, Chang HH, Huang MC, et al. (2011) Insulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma. Cancer Sci 102: 2191-2198.
13. Jeng YM, Chang CC, Hu FC, Chou HY, Kao HL, et al. (2008) RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma. Hepatology 48: 1118-1127.
14. Kabbarah O, Nogueira C, Feng B, Nazarian RM, Bosenberg M, et al. (2010) Integrative genome comparison of primary and metastatic melanomas. PLoS One 5: e10770.
15. Yaniv K, Yisraeli JK, (2002) The involvement of a conserved family of RNA binding proteins in embryonic development and carcinogenesis. Gene 287: 49-54.
16. Mueller F, Bommer M, Lacher U, Ruhland C, Stagge V, et al. (2003) KOC is a novel molecular indicator of malignancy. Br J Cancer 88: 699-701.
17. Wang JB, Erickson JW, Fuji R, Ramachandran S, Gao P, et al. (2010) Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 18: 207-219.
18. Liao B, Hu Y, Herrick DJ, Brewer G, (2005) The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells. J Biol Chem 280: 18517-18524.
19. Nielsen FC, Nielsen J, Kristensen MA, Koch G, Christiansen J, (2002) Cytoplasmic trafficking of IGF-II mRNA-binding protein by conserved KH domains. J Cell Sci 115: 2087-2097.
20. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, et al. (2010) Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141: 129-141.
21. Hock J, Weinmann L, Ender C, Rudel S, Kremmer E, et al. (2007) Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. EMBO Rep 8: 1052-1060.
22. Liao B, Hu Y, Brewer G, (2011) RNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like growth factor II signaling after ionizing radiation. J Biol Chem 286: 31145-31152.
23. Liao B, Patel M, Hu Y, Charles S, Herrick DJ, et al. (2004) Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells. J Biol Chem 279: 48716-48724.
24. Suvasini R, Shruti B, Thota B, Shinde SV, Friedmann-Morvinski D, et al. (2011) Insulin Growth Factor-2 Binding Protein 3 (IGF2BP3) Is a Glioblastoma-specific Marker That Activates Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase (PI3K/MAPK) Pathways by Modulating IGF-2. J Biol Chem 286: 25882-25890.
25. Vikesaa J, Hansen TV, Jonson L, Borup R, Wewer UM, et al. (2006) RNA-binding IMPs promote cell adhesion and invadopodia formation. EMBO J 25: 1456-1468.
26. Shimizu T, Ishikawa T, Iwai S, Ueki A, Sugihara E, et al. (2012) Fibroblast Growth Factor-2 Is an Important Factor that Maintains Cellular Immaturity and Contributes to Aggressiveness of Osteosarcoma. Mol Cancer Res 10: 454-468.
27. Samanta S, Sharma VM, Khan A, Mercurio AM (2012) Regulation of IMP3 by EGFR signaling and repression by ERbeta: implications for triple-negative breast cancer. Oncogene.
28. Toledano H, D'Alterio C, Czech B, Levine E, Jones DL, (2012) The let-7-Imp axis regulates ageing of the Drosophila testis stem-cell niche. Nature 485: 605-610.
29. Berdasco M, Esteller M, (2010) Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev Cell 19: 698-711.
30. Do SI, Kim YW, Park HR, Park YK, (2008) Expression of insulin-like growth factor-II mRNA binding protein 3 (IMP3) in osteosarcoma. Oncol Res 17: 269-272.
31. Chen P, Wang SJ, Wang HB, Ren P, Wang XQ, et al. (2012) The distribution of IGF2 and IMP3 in osteosarcoma and its relationship with angiogenesis. J Mol Histol 43: 63-70.
32. Visvader JE, (2011) Cells of origin in cancer. Nature 469: 314-322.
33. Magee JA, Piskounova E, Morrison SJ, (2012) Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21: 283-296.